NASDAQ: LXEOLexeo Therapeutics Inc Stock Ownership - Who owns Lexeo Therapeutics?
Insider buying vs selling
Have Lexeo Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Richard Nolan Townsend | Chief Executive Officer | 2026-04-06 | 55,000 | $5.69 | $313.12kSell |
| Jose Manuel Otero | Chief Operating Officer | 2026-03-13 | 5,930 | $2.64 | $15.68kBuy |
| Richard Nolan Townsend | Chief Executive Officer | 2026-03-13 | 2,623 | $2.64 | $6.94kBuy |
| Jose Manuel Otero | Chief Operating Officer | 2026-02-18 | 3,016 | $6.40 | $19.29kSell |
| Richard Nolan Townsend | Chief Executive Officer | 2026-02-18 | 10,173 | $6.38 | $64.92kSell |
| Jenny Robertson | Chief Legal Officer | 2025-11-18 | 549 | $9.27 | $5.09kSell |
| Eric Adler | Chief Medical Officer | 2025-11-18 | 615 | $9.27 | $5.70kSell |
| Jose Manuel Otero | Chief Operating Officer | 2025-11-18 | 721 | $9.27 | $6.68kSell |
| Tai Sandi See | Chief Development Officer | 2025-11-18 | 386 | $9.27 | $3.58kSell |
| Richard Nolan Townsend | Chief Executive Officer | 2025-11-18 | 1,127 | $9.27 | $10.45kSell |
LXEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LXEO insiders and whales buy or sell their stock.
LXEO Shareholders
What type of owners hold Lexeo Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Janus Henderson Group PLC | 7.44% | 5,509,635 | $31.79M | Institution |
| Ra Capital Management LP | 6.75% | 5,000,000 | $28.85M | Institution |
| Blackrock Inc | 6.62% | 4,907,563 | $28.32M | Institution |
| Paradigm Biocapital Advisors LP | 6.43% | 4,763,198 | $27.48M | Institution |
| Vestal Point Capital LP | 6.04% | 4,475,000 | $25.82M | Institution |
| Frazier Life Sciences Management LP | 5.97% | 4,424,725 | $25.53M | Institution |
| Vanguard Group Inc | 5.26% | 3,894,310 | $22.47M | Institution |
| Citadel Advisors LLC | 5.09% | 3,774,317 | $21.78M | Institution |
| Avoro Capital Advisors LLC | 4.45% | 3,300,000 | $19.04M | Institution |
| Affinity Asset Advisors LLC | 4.32% | 3,200,000 | $18.46M | Institution |
LXEO vs Biotech Stocks
Lexeo Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.